Platelets are a heterogeneous small anucleate blood cell population with a central role both
in physiological haemostasis and in pathological states, spanning from thrombosis to …

Cardiovascular ailments are the number one cause of mortalities throughout the globe with
17.9 million deaths per year. Platelet activation and aggregation play a crucial role in the …

Objective To test a scalable health system intervention to improve long term adherence to
secondary prevention treatments among patients who have had a recent myocardial …

Acute coronary syndrome (ACS) is principally driven by platelet aggregation. Dual
antiplatelet therapy (DAPT) has demonstrated a reduction in recurrent ischemic events. The …

While blood‐contacting materials are widely deployed in medicine in vascular stents,
catheters, and cannulas, devices fail in situ because of thrombosis and restenosis …

Metastasis requires that cancer cells survive in the circulation, colonize distant organs, and
grow. Despite platelets being central contributors to hemostasis, leukocyte trafficking during …

El presente documento es una actualización de las recomendaciones de práctica clínica
para el manejo de los factores de riesgo cardiovascular (FRCV) en la diabetes mellitus. Este …

Ethnopharmacological relevance Dual antiplatelet therapy (DAPT) with aspirin (ASA) and
clopidogrel (CLP) has been consistently shown clinical effectiveness in patients with …

Background: Patients using dual antiplatelet therapy after percutaneous coronary
intervention are at risk for bleeding. It is currently unknown whether thrombin generation can …

As integral parts of pathological arterial thrombi, platelets are the targets of pharmacological
regimens designed to treat and prevent thrombosis. A detailed understanding of platelet …